Asked by: Rachel Gilmour (Liberal Democrat - Tiverton and Minehead)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his department is taking to help ensure trusts have sufficient access to operational capital funding to repair buildings, replace old equipment, and provide a suitable environment for patients.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government is committed to delivering a National Health Service that is fit for the future through our 10-Year Health Plan, and we recognise the importance of supporting NHS trusts to manage and maintain their estates using operational capital allocations.
The Government’s recently published 10 Year Infrastructure Strategy set out 10-year maintenance budgets for the public estate, confirming £6 billion per year for the maintenance and repair of the NHS estate up to 2034/35.
Within this overall figure, the Government is providing over £4 billion in operational capital in 2025/26 and has now allocated a further £15.6 billion directly to providers over the following four years, from 2026/27 to 2029/30. Providers have also been given further five-year operational capital planning assumptions, covering 2030/31 to 2034/35, allowing them to plan longer term with confidence and accelerate investment decisions aligned to local priorities, including repairs, maintenance, and ensuring suitable patient environments.
In addition to operational capital, the Estates Safety Fund, established in 2025/26, will continue, with £6.75 billion investment over the next nine years to target the most critical building repairs and ensure safe environments for healthcare delivery.
Asked by: Richard Holden (Conservative - Basildon and Billericay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the Government has (a) commissioned and (b) plans to commission studies using (i) genomic datasets, (ii) UK Biobank and (iii) Genomics England to estimate levels of (A) inbreeding and (B) runs of homozygosity and F coefficients across UK populations.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department has not, and has no plans to, commission such research via Genomics England, UK Biobank, Our Future Health, or the National Institute for Health and Care Research.
Asked by: Johanna Baxter (Labour - Paisley and Renfrewshire South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, which health bodies from England, Wales, Scotland and Northern Ireland were involved in Exercise Pegasus.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Exercise PEGASUS, the largest simulation of a pandemic in the United Kingdom’s history, involved all four nations and thousands of participants across different parts of the exercise. Participants that are health bodies included, but were not limited to:
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential merits of ensuring that rare autoimmune rheumatic disease patients have named care coordinators.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
We are aware there remains unmet need on coordination of care for people with rare diseases and work is underway to improve this.
Integrated care boards (ICBs) are responsible for working with their local communities to understand the needs of the local populations and make decisions about how best to commission services, including for those with rare autoimmune rheumatic disease.
We are improving coordination of care for all rare diseases as a priority under the UK Rare Diseases Framework. England’s Rare Diseases Action Plans details a range of measures to improve coordination of care, including work against Action 37 on co-ordination of care for multi-system disorders. NHS England is also committed to include the definition of coordination of care in all new and revised services specifications for patients with rare diseases. The National Institute of Health and Care Research has commissioned research to provide the evidence needed to operationalise better co-ordination of care for rare diseases in the National Health Service.
Asked by: Calvin Bailey (Labour - Leyton and Wanstead)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential implications for his policies of the evidence presented in Prostate Cancer Research’s report entitled Prostate Cancer Screening: The Impact on the NHS, on targeted prostate cancer screening for high-risk men; and if he will ensure that this is considered as part of the UK National Screening Committee’s review of prostate cancer screening options.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK National Screening Committee (UK NSC) Secretariat has noted Prostate Cancer Research’s report entitled Prostate Cancer Screening: The Impact on the NHS and has discussed it with the chair of the UK NSC.
The UK NSC is currently undertaking a new evidence review of prostate cancer screening at both a population level and for targeted high-risk groups such as black men and men with a family history of prostate cancer. We anticipate a public consultation on the findings of this review soon and a recommendation by the UK NSC in the first quarter of next year.
Asked by: Oliver Dowden (Conservative - Hertsmere)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to promote NHS innovation in nano surgery.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
As set out in the 10-Year Health Plan and Life Sciences Sector Plan, the Department encourages innovation in the health sector that helps to support the three big shifts in healthcare: moving care from hospitals to communities; transitioning from analogue to digital; and focusing on prevention over treatment.
The Department is actively supporting the development and evaluation of game-changing innovations as well as the adoption of technologies to give our world leading clinicians the technology and skills to improve outcomes for patients.
Improving innovation, adoption, and procurement of game-changing technology, including nano surgery, will help the National Health Service secure the best possible outcomes for patients whilst also delivering greater value-for-money and unlocking further economic growth. In addition, the National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately drive up this country’s cancer survival rates.
The Department funds research through the National Institute for Health and Care Research (NIHR). As well as funding research directly through NIHR programmes, the Department also funds NIHR infrastructure which are centres of excellence and collaborations, services, and facilities to support health and care research.
The NIHR research infrastructure drives innovation through research across a range of health and care areas, including nano surgery. For example, the Surgical and Perioperative Care Translational Research Collaboration brings together NIHR infrastructure to develop new surgical interventions, improving patient safety and patient care before and after surgery.
The NIHR HealthTech Research Centres (HRCs) work with industry to develop medical devices, diagnostics, and digital technologies. The NIHR Accelerated Surgical Care HRC’s focus is on minimally invasive therapies which enable surgical care to be delivered with greater precision, minimal trauma, and improved outcomes.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help tackle increases in legal costs for clinical negligence.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The rising costs of clinical negligence claims against the National Health Service in England are of great concern to the Government. Costs have more than doubled in the last 10 years and are forecast to continue rising, putting further pressure on NHS finances.
As announced in the recently published 10-Year Health Plan for England, David Lock KC will be providing expert policy advice on the rising legal costs of clinical negligence and how we can improve patients’ experience of claims, ahead of a review by the Department in the autumn.
The results of David Lock’s work will inform future policy making in this area. No decisions on policy have been taken at this point, and the Government will provide an update on the work done and next steps in due course.
Asked by: Richard Holden (Conservative - Basildon and Billericay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of updating the international frozen food storage standard from –18°C to –15°C, including the potential impact on (a) energy costs for producers and retailers, (b) efficiencies in the food supply chain and (c) consumer prices; and whether the Government plans to support such a change in international standards.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government welcomes new and innovative steps taken by any businesses to produce and supply food sustainably, providing they can demonstrate the food they place on the market is safe.
There is no legal requirement for frozen food to be stored at -18°C in general, but freezing remains a critical control step in some cases, such as killing parasites in fish intended to be eaten raw, and these requirements continue to apply.
We are aware that parts of the food industry are exploring raising frozen food storage temperatures from -18°C to -15°C to reduce energy use and support sustainability goals. While this evidence has not yet been shared with the Food Standards Agency, we are engaging with food businesses to understand potential implications. The Government will continue to monitor industry trials and evidence related to international frozen food storage standards.
Raising frozen food storage temperatures could reduce energy use for food business operators, which may help lower operating costs. At present, there is no clear evidence that such changes would lead to lower prices for consumers.
Any food business considering changes to frozen food storage temperatures must ensure food safety management systems remain compliant with legal requirements.
Asked by: Pippa Heylings (Liberal Democrat - South Cambridgeshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will consider providing financial support for children living with Coeliac disease.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
We recognise the pressures families face in managing coeliac disease, particularly the additional costs of maintaining a strict gluten-free (GF) diet, which is the only effective treatment for this condition.
The national prescribing position in England remains that GF bread and mixes can be provided to coeliac patients on a National Health Service prescription, and a wide range of these items continue to be listed in Part XV of the Drug Tariff. This means that prescribers can issue NHS prescriptions, based on a shared decision between prescriber and patient, while also being mindful of local and national guidance. Children under 16 years old, and those aged between 16 to 18 years old in full-time education, are entitled to free NHS prescriptions, ensuring that where integrated care boards support GF prescribing, eligible children can access these products without charge.
Asked by: Oliver Dowden (Conservative - Hertsmere)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to promote NHS innovation in liquid biopsies.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to funding innovative technologies, including multi-cancer detection (MCD) tests such as liquid biopsies, to improve early cancer diagnosis rates for cancer patients in the National Health Service. The Office for Life Sciences’ Cancer Healthcare Goals programme is providing funding for a National Institute for Health and Care Research led trial to assess the clinical and cost effectiveness of MCD tests in primary care for patients presenting with non-specific abdominal symptoms. The programme has also provided £2.35 million of funding to support the research and development of the miONCO-Dx multi-cancer early detection test, which can identify 12 of the most lethal and common cancers at even the earliest stages of the disease course.